Results 11 to 20 of about 34,196 (189)
Frontiers in Microbiology, 2022 The human T-lymphotropic virus 1 (HTLV-1) and 2 (HTLV-2) can be transmitted between humans by mechanisms associated with horizontal and vertical routes.
Aldemir Branco Oliveira-Filho +16 more
doaj +1 more source
Frontiers in Microbiology, 2020 Human T-cell leukemia virus type 1 (HTLV-1) was the first retrovirus described as a causative agent for human disease. In the field of ophthalmology, a close relationship between HTLV-1 infection and uveitis was identified through a series of clinical and laboratory studies in the late 1980s-1990s.
Koju Kamoi, Koju Kamoi, Koju Kamoi
openaire +3 more sources
Frontiers in Public Health, 2022 A multi-epitope protein expressed in a prokaryotic system, including epitopes of Env, Gag, and Tax proteins of both HTLV-1 and HTLV-2 was characterized for HTLV-1/2 serological screening.
Gabriela de Melo Franco +22 more
doaj +1 more source
mSphere, 2020 Provirus mutations of human T-lymphotropic virus 1 (HTLV-1), mostly the lack of the 5′ long terminal repeat (LTR) genomic region, have been described and associated with severe adult T cell leukemia/lymphoma (ATLL), non-sense point mutations with low ...
Karoline Rodrigues Campos +1 more
doaj +1 more source
Epidemiological Aspects and World Distribution of HTLV-1 Infection
Frontiers in Microbiology, 2012 The human T-cell leukemia virus type 1 (HTLV-1), identified as the first human oncogenic retrovirus 30 years ago, is not an ubiquitous virus. HTLV-1 is present throughout the world, with clusters of high endemicity located often nearby areas where the ...
Antoine eGessain +5 more
doaj +1 more source
PLoS Neglected Tropical Diseases, 2023 BackgroundHuman T-cell leukemia virus type 1 (HTLV-1) causes adult T-cell leukemia-lymphoma (ATL) and HTLV-1-associated myelopathy-tropical spastic paraparesis (HAM/TSP) with a poor prognosis.
Akiko Kowada
doaj +1 more source
Making Visible HTLV Infection in a Non-endemic Area of Argentina
Frontiers in Medicine, 2022 In Argentina, the human T-cell lymphotropic virus type 1 (HTLV-1) infection has been documented mainly among blood banks with a prevalence of ~0.02–0.046% for Buenos Aires city, 0.8% for the northeast, and 1% for the northwest; both areas are considered ...
Federico R. Simioli +7 more
doaj +1 more source
Journal of Clinical Pathology, 2000 Human T lymphotropic virus type 1 (HTLV-1) causes disabling and fatal diseases, yet there is no vaccine, no satisfactory treatment, and no means of assessing the risk of disease or prognosis in infected people. Recent research on the molecular virology and immunology of HTLV-1 shows the importance of the host's immune response in reducing the risk of ...
openaire +2 more sources
Regulation of HTLV-1 transformation [PDF]
Bioscience Reports, 2022 AbstractHuman T-cell leukemia virus type 1 (HTLV-1) is the only identified oncogenic human retrovirus. HTLV-1 infects approximately 5–10 million people worldwide and is the infectious cause of adult T-cell leukemia/lymphoma (ATL) and several chronic inflammatory diseases, including HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP ...
Kyle J. Ernzen, Amanda R. Panfil
openaire +2 more sources
The roles of acquired and innate immunity in human T-cell leukemia virus type 1-mediated diseases
Frontiers in Microbiology, 2012 Human T-cell leukemia virus type 1 (HTLV-1) causes adult T-cell leukemia (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis in small subsets of HTLV-1-carriers.
Mari eKannagi +4 more
doaj +1 more source